Skip to main content

Table 1 Overview of clinical trials investigating the therapeutic usefulness of the UPR

From: Drugging the unfolded protein response in acute leukemias

Compound

Molecular target

Disease

Stage of clinical development

References

Epigallocatechin gallate (EGCG)

GRP78

Alzheimer’s disease

Clinical, phase 2 and 3

NCT00951834

PAT-SM6

GRP78

Multiple myeloma

Clinical, phase 1

NCT01727778, Rasche et al. [115]